Trends in intravenous immunoglobulin use in New South Wales, Australia.

James G WoodAnita E HeywoodPeta M DenningtonAndrew R LloydJohn B Ziegler

Published in: Internal medicine journal (2023)

Clinically acceptable measures to improve management of IVIg supply are needed including optimising dose, frequency and duration of treatment. Formal evaluation of IVIg versus alternatives, including cost-effectiveness and comparative efficacy, is warranted.

Keyphrases